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Abstract: Drug resistance of pathogenic microorganisms has become a global public health problem,
which has prompted the development of new materials with antimicrobial properties. In this context,
antimicrobial nanohybrids are an alternative due to their synergistic properties. In this study, we
used an environmentally friendly one-step approach to synthesize graphene oxide (GO) decorated
with silver nanoparticles (GO–AgNPs). By this process, spherical AgNPs of average size less than
4 nm homogeneously distributed on the surface of the partially reduced GO can be generated
in the absence of any stabilizing agent, only with ascorbic acid (L-AA) as a reducing agent and
AgNO3 as a metal precursor. The size of the AgNPs can be controlled by the AgNO3 concentration
and temperature. Smaller AgNPs are obtained at lower concentrations of the silver precursor and
lower temperatures. The antimicrobial properties of nanohybrids against Gram-negative bacteria
Escherichia coli and Pseudomonas aeruginosa, Gram-positive Staphylococcus aureus, and the yeast Candida
albicans were found to be concentration- and time-dependent. C. albicans and S. aureus showed the
highest susceptibility to GO–AgNPs. These nanohybrids can be used as nanofillers in polymer
nanocomposites to develop materials with antimicrobial activity for applications in different areas,
and another potential application could be cancer therapeutic agents.
Keywords: graphene oxide; silver nanoparticles; nanohybrids; antimicrobial activity
1. Introduction
The emergence of nanotechnology has led to the development of nanomaterials, including
inorganic nanoparticles with antimicrobial properties, such as silver nanoparticles (AgNPs). These
nanoparticles have been proposed as an alternative for mitigating the incidence of healthcare-associated
infectious diseases and as a possible solution to the increasing antibiotic resistance problem. Several
physical, chemical, and biological methods have been reported to synthesize AgNPs [1–5]. Among
chemical processes, chemical reduction, based on the reduction of a silver salt solution by a reducing
agent, is the most simple, cost-effective, and frequently applied method. The reduction of silver ions
(Ag+) results in silver atoms (Ag0), which agglomerate into oligomeric clusters leading to the formation
of colloidal AgNPs. However, they have low colloidal stability when used in liquid systems, and
aggregation to form clusters occurs owing to the high surface area of nanoparticles. Stabilizing agents
in the synthesis of AgNPs play a crucial role in the formation of nanoparticles with controlled size
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and a well-defined shape [6]. Nanoparticle size and shape dictate its physicochemical properties [7,8].
Thus, several studies have reported that the antimicrobial activity of AgNPs is both size and shape
dependent [7,9,10]. Graphene oxide (GO), the oxidized form of graphene, is an appropriate material to
disperse and stabilize silver since it combines a large specific surface area and abundant oxygenated
functional groups. In addition, GO produces stable dispersions in water. The oxygen-containing
groups act as anchoring sites for the attachment of metal nanoparticles. GO sheets act as a support for
growth and stabilization of AgNPs.
The synthesis of GO–AgNP hybrids by different approaches has been reported, where different
reducing agents have been used. Moreover, in most of these studies, a stabilizing agent is used to
prevent silver nanoparticle agglomeration and control its structure. Bao et al. used hydroquinone
as the reductant and citrate as the stabilizer [11]. Das et al. employed NaBH4 in the absence and
presence of trisodium citrate as a stabilizing agent [12,13]. Shen et al. used a mixed reducing agent,
ethylene glycol and NaBH4 [14]. In the study of Chook et al. a microwave approach with glucose as a
reducing agent was used [15]. Ma et al. also reported the preparation of Ag–GO composites under
ultrasonication using glucose as a reducing agent [16]. Tang et al. [17], Fonseca de Faria et al. [18],
and Yuan et al. [19] used sodium citrate as a reducing and stabilizing agent at boiling temperature,
130 ◦C and 95 ◦C, respectively. Hydrazine monohydrate was used as a reductant by Cai et al. to
prepare polyethyleneimine-modified reduced graphene oxide-AgNP hybrids [20]. KOH was used
as a reducing agent at boiling temperature in the work reported by Pasricha et al. [21]. In the study
by Hui et al. AgNP–GO composites were fabricated under ultrasonication with ascorbic acid as the
reductant [22]. Shen et al. synthesized Ag-GO composites at 160 ◦C with ascorbic acid as the reductant
and an ionic liquid as a dispersing agent [23]. Several of the mentioned methods have the disadvantage
of using toxic reducing agents in the synthesis process.
It has been demonstrated that in these nanostructures GO and AgNPs work synergistically to
enhance their properties, such as higher antimicrobial and catalytic activities and thermal conductivity.
The synergistic properties of these hybrid materials have proven to be useful in a variety of applications
(electronics, catalysis, electrochemical biosensing, drug delivery, and antimicrobial agents) [24–29].
Both graphene and AgNPs have been combined with polymer matrices to develop antimicrobial
materials [30]. Polymer nanofibrous patches containing antimicrobial agents have been fabricated via
electrospinning for application in various fields [31]. More recently, Alenezi et al. [32] developed a new
route that improves the quality and production yield of nanofibers by using the pressurized gyration
technique. The microbial properties of graphene nanoplatelet-loaded polymeric fibers obtained by this
process have been studied by Matharu et al. [33].
The increasing prevalence of antimicrobial resistance has become one of the major health
problems worldwide; thus, the need to develop new therapeutic strategies against multi-drug resistant
microorganisms is crucial. Many infectious agents are transmitted by human contact or through objects,
food, water, and animals. Therefore, the use of antimicrobial materials in the composition, for instance,
of biomedical devices or in food transport containers can help reduce microbial contamination and
pathogen transmission [34].
In this study, graphene oxide-silver nanoparticle nanohybrids (GO–AgNPs) were synthesized
via a one-step environmentally friendly approach using an aqueous dispersion of GO, AgNO3
as a metal precursor, and ascorbic acid as a green reductant, without any stabilizing agent. The
physicochemical properties of the GO–AgNP nanohybrids and the influence of metal precursor
concentration and temperature on AgNP size were evaluated. In addition, the antimicrobial activity
of GO and nanohybrids against Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa,
Gram-positive bacterium Staphylococcus aureus, and the yeast Candida albicans was also investigated.
The AgNPs had a spherical shape and an average size less than 4 nm. The nanohybrids exhibited
species-specific antimicrobial activities.
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2. Materials and Methods
2.1. Materials
Graphite flakes were purchased from Alfa Aesar (Karlsruhe, Germany) (99.8%, 325 mesh) and
sodium nitrate (NaNO3) was obtained from Merck (Darmstadt, Germany). Sulphuric acid (H2SO4,
98%), potassium permanganate (KMnO4), hydrogen peroxide (H2O2, 30 wt% aqueous solution),
hydrochloric acid (HCl, 37% aqueous solution), and ammonium hydroxide were acquired from Panreac
(Barcelona, Spain), while L-ascorbic acid (L-AA), silver nitrate (AgNO3), phosphate-buffered saline
(PBS), and culture medium Roswell Park Memorial Institute (RPMI) were supplied by Sigma–Aldrich
(Munich, Germany, and St. Louis, MO, USA). Escherichia coli ATCC 25922 (Gram-negative bacteria)
and Staphylococcus aureus ATCC 25923 (Gram-positive bacteria) were obtained from CECT (Spanish
Type Culture Collection, Valencia, Spain), Candida albicans SC5314 was obtained from the American
Type Culture Collection (ATCC, Manassas, Virginia, WV, USA), and brain heart infusion (BHI) broth
and Mueller–Hinton broth were supplied by Condalab (Madrid, Spain). All chemicals were used as
received without further purification.
2.2. Synthesis of Graphene Oxide (GO) and Graphene Oxide–Silver Nanoparticle Nanohybrids (GO–AgNPs)
To obtain graphene oxide, first, graphite oxide (GrO) was prepared from the oxidation of graphite,
which was then exfoliated to obtain GO. GrO was synthesized from natural graphite flakes following a
modified Hummers method as described in our previous work [35]. Thus, 6 g of KMnO4 was slowly
added to a mixture of graphite (2 g), H2SO4 (50 mL), and NaNO3 (1 g) at 0 ◦C. After 1 h at 35 ◦C in a
water bath, 100 mL de-ionized water was added slowly. Then, 10 mL of 30% H2O2 was incorporated
into the solution and followed by centrifugation. The solid was then washed repeatedly with water,
HCl and deionized water, until neutral pH. Finally, the solid was separated by centrifugation and
re-dispersed in water to obtain GrO by freeze-drying. The exfoliation of GrO by ultrasonication
(Bandeline Sonopuls HD 3200 homogenizer, Berlin, Germany) led to GO.
GO–AgNP nanohybrids were synthesized via the in situ method, through the simultaneous
reduction of the metal precursor and graphene oxide (GO) using L-ascorbic acid as a green reductant.
GrO powder (0.5 mg/mL) was dispersed in deionized water using an ultrasonic bath for 1 h to obtain
GO, and the pH was adjusted to 10 by the addition of ammonium hydroxide. Then, the desired amount
of an aqueous AgNO3 solution (to reach 1.5 mM or 2.0 mM) was slowly added to the dispersion under
continuous stirring in the absence of light and heated at 60 ◦C in an oil bath. Next, an aqueous solution
of L-AA was added at a concentration that maintained the weight ratio between L-AA and AgNO3
fixed at 2.07. The reaction mixture was held at 60 ◦C for 1 hour and was then cooled, dialyzed, and
centrifuged at high speed repeatedly. Finally, GO–AgNP powder was obtained by freeze-drying. The
experiments were also carried out at 80 ◦C to investigate the effect of temperature on the properties of
AgNPs. Table 1 lists the prepared nanohybrid sample names and the reaction conditions.
Table 1. Nomenclature and reaction conditions for graphene oxide (GO) decorated with silver
nanoparticle (GO–AgNP) nanohybrids.
Sample Experimental Conditions
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2.3. Characterization
Fourier transform infrared spectroscopy (FTIR), ultraviolet–visible absorption spectroscopy
(UV–vis), X-ray photoelectron spectroscopy (XPS), Raman spectroscopy, X-ray diffraction (XRD), and
transmission electron microscopy (TEM) were employed to evaluate the structure and the morphology
of the samples.
2.3.1. FTIR Analysis
FTIR spectra of GO and GO–AgNPs were recorded on a Thermo Nicolet iS10 spectrometer
(Thermo Fisher Scientific, Madison, WI, USA) equipped with an attenuated total reflectance accessory
(ATR).
2.3.2. UV–vis Analysis
A Perkin Elmer Lambda 25 spectrometer (Shelton, CT, USA) was used to collect the UV–vis
absorption spectra between 200 and 800 nm of graphene materials.
2.3.3. XPS Analysis
The analysis of the surface chemistry of GO and GO–AgNPs was performed by XPS on a SPECS
system with a monochromatic Al Kα X-ray source (1486.6 eV) and a Phoibos 150 1D-DLD analyzer
(Berlin, Germany). The core level spectra were obtained at a photoelectron take-off angle of 90◦,
measured with respect to the sample surface. The XPS survey–scan spectra were collected using a pass
energy of 80 eV, 1 eV energy step, and 0.1 s dwell time. The individual high-resolution spectra were
acquired using a pass energy of 30 eV, 0.1 eV energy step, and 0.1 s dwell time.
2.3.4. Raman Analysis
Raman spectra of GO and GO–AgNPs were obtained with a Renishaw Invia microscope
(Gloucestershire, UK) with a laser frequency of 514 nm as an excitation source. The spectra were
measured from 500 to 3500 cm−1.
2.3.5. XRD Analysis
The XRD spectra of graphene materials were recorded using a Malvern Panalytical (Almelo, the
Netherlands) X’PERT PRO automatic diffractometer operating at 40 kV and 40 mA in theta–theta
configuration, a secondary monochromator with Cu-Kα radiation (λ = 1.5418 Å), and a PIXcel solid
state detector (active length in 2θ 3.347◦). Data were collected from 1 to 50◦ 2θ for GO and from 1 to
90◦ 2θ for GO–AgNP samples (step size = 0.026◦ and time per step = 80 s, total time 20 min) at room
temperature. A variable divergence slit giving a constant 5 mm area of sample illumination was used.
The interlayer separation in the graphene material was calculated by Bragg´s law (λ = 2d sinθ).
2.3.6. TEM Analysis
TEM images were taken using a Philips Tecnai G2 20 TWIN TEM instrument (Eindhoven, the
Netherlands) at 200 kV accelerated voltage. A drop of the diluted GO–AgNP nanohybrid suspensions
was placed onto coated cooper grids.
2.3.7. Thermogravimetric Analysis (TGA)
TGA tests were performed on a TG-Q-500 (TA instruments, New Castle, DE, USA) under nitrogen
at a heating rate of 10 ◦C/min, from 40 to 600 ◦C.
Nanomaterials 2020, 10, 376 5 of 22
2.4. Microbial Strains and Culture
Three well-described bacterial species and one clinically relevant yeast were evaluated:
Gram-negative bacteria E. coli ATCC 25922 and P. aeruginosa ATCC 27853, the Gram-positive bacterium
S. aureus ATCC 25923, and C. albicans SC5314. Briefly, microorganisms were harvested on plate count
agar (PCA) for 24 h at 37 ◦C from frozen stock, and inoculum was prepared from single colonies grown
to stationary phase in BHI broth at 37 ◦C overnight in an orbital incubator under 100 rpm. Cultures
were centrifuged (3000 × g, 10 min) and washed twice in PBS. A cell suspension adjusted to a cell
density equivalent to 0.5 McFarland (representing approximately 1–5 × 108 cells/mL) was prepared
using sterile saline for bacteria, and C. albicans was adjusted at 1 × 106 cells/mL upon counting cells in
a hemocytometer. Viable counts were enumerated after overnight incubation at 37 ◦C in PCA.
2.5. Antimicrobial Activity Assays for GO and GO–AgNP Nanohybrids. Determination of the Minimum
Inhibitory Concentrations (MICs)
The minimum inhibitory concentration (MIC) is defined as the lowest concentration, recorded
in mg/L or µg/mL, of an agent that inhibits the growth of a microorganism. In the present study,
the MIC of four microorganisms was determined: C. albicans SC5314, S. aureus ATCC 25923, E. coli
ATCC 25922, and P. aeruginosa ATCC 27853. The EUCAST broth microdilution method (EUCAST
EDef 7.3.1) was used to establish the MICs of GO and GO–AgNPs since it is a reference method for
antimicrobial susceptibility testing, and one of its main purposes is to establish the activity of new
antimicrobial agents. Stock solutions of graphene derivatives at 200-fold the concentration to be
analyzed were prepared in order to maintain the same concentration of culture medium in each well
of the microdilution plate. Next, these solutions were diluted 100-fold in the corresponding culture
medium, which was previously prepared at 2-fold concentration. The culture medium was RPMI with
2% of glucose (RPMI 2% G) and Mueller–Hinton broth (recommended by EUCAST) for C. albicans
and bacteria, respectively. Subsequently, 100 µL of each dilution was added to each well; the final
test concentration for each compound ranged from 0.25 µg/mL to 128 µg/mL. Then, the microbial
suspension was diluted 1:10 for C. albicans and 1:100 for bacteria in sterile distilled water, and 100 µL
was pipetted into each well, obtaining the final inoculum concentration of 5 ×104 CFU/mL and 5 × 105
CFU/mL, respectively. Finally, the microdilution plates were read using a microdilution plate reader
(iMark Microplate Reader, BioRad, Hercules, CA, USA) at a wavelength of 450 nm at 0 h and 24 h at
37 ◦C. The MIC corresponds to the concentration of the compound that resulted in an absorbance
reduction of 50% or greater with respect to the absorbance found in the wells of the growth control.
2.6. Microbial Growth Kinetics Assay in the Presence of GO–AgNP Nanohybrids
The four previously mentioned microorganisms were analyzed at the final inoculum density of
5 × 104 CFU/mL and 5× 105 CFU/mL for yeast and bacteria, respectively. The highest GO concentration
in the MIC determination assay (128 µg/mL) was tested along with three concentrations of GO–AgNPs,
selected on the basis of the MIC value of each microorganism: 64 µg/mL, 32 µg/mL, and 16 µg/mL
for C. albicans and 128 µg/mL, 64 µg/mL, and 32 µg/mL for S. aureus, E. coli, and P. aeruginosa. Briefly,
a microplate was loaded with culture medium, the GO–AgNP hybrid, and the microorganism as
mentioned above. The microorganism in the culture medium was considered the growth control
(GC), and the different concentrations of the compounds without microorganisms but with the culture
medium, the blank. The microplates were placed in a microplate reader (BioScreen C, Labsystem,
Helsinki, Finland) configured to read the absorbance at 430–580 nm every hour for 72 hours at 37 ◦C.
Five wells for each compound concentration were used, and the assay was performed in duplicate.
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3. Results and Discussion
3.1. Characterization
GO and GO–AgNPs were physicochemically characterized, firstly, to confirm their formation,
and secondly, because the antimicrobial properties depend on the physicochemical properties such as
chemical composition, shape, and size of the AgNPs.
3.1.1. Structure and Morphology
FTIR Analysis
The FTIR spectra of GO and GO–AgNP nanohybrids are displayed in Figure 1a. The GO spectrum
shows various bands associated with the vibrational modes of different oxygen-containing functional
groups. The band at 3800–3000 cm−1 is attributed to the stretching vibrations of structural OH groups
and physisorbed water molecules. The bands at 1734 cm−1 and 1621 cm−1 are related to the C=O
carbonyl stretching of COOH groups situated at the edges of the GO sheets and to the deformation
vibration of water molecules, respectively. The peaks at 1362 cm−1 and 1052 cm−1 arise from the
bending of tertiary C-OH groups and the vibration of C–O of epoxide groups (C–O–C), respectively.
The peak at 1225 cm−1 is assigned to C−O−C stretching. For GO–AgNP nanohybrids, the weakening
of the carbonyl and hydroxyl bands is observed, as well as the elimination of the band at 1621 cm−1.
These results indicate the simultaneous partial reduction of GO.
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UV-Vis Analysis
The UV–vis spectroscopy was used to confirm the formation of GO–AgNP nanohybrids.
The UV–vis spectra of GO and GO–AgNP nanohybrids are shown in Figure 1b. For GO, the
maximum absorption peak at 230 nm is ascribed to the electronic π→ π * transitions of aromatic C-C
bonds, and the shoulder at ~300 nm corresponds to n→ π * transitions of C=O bonds. The absorption
spectrum of GO–AgNP hybrid exhibits the red shift of the maximum peak of GO, from 230 to 265
nm, suggesting the simultaneous partly reduction of GO during the preparation of the – g P
nanohybrids and therefore the recovery of the electronic conjugation of the graphene sheets. In addition,
the spectrum shows the characteristic surface plasmon resonance (SPR) band of AgNPs (~404 nm),
which confirms the presence of small spherical-shaped AgNPs on GO [36]. UV-Vis spectroscopy was
also used to analyze the effect of reaction temperature and the AgNP precursor concentration on the
synthesis of GO–AgNP nanohybrids. As can be seen from Figure 1b, the intensity and shape of the
SPR absorption band remain similar at both temperatures when 1.50 mM AgNO3 was used. However,
the absorbance peak becomes more intense as temperature increases in the case of 2.00 mM AgNO3,
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which can be due to an increase of the number of nanoparticles formed. The position of the SPR band
remains practically unchanged as the temperature and silver precursor concentration increase.
XPS Analysis
XPS characterization was performed to prove both the reduction of GO and the formation of
AgNPs. XPS survey spectra of GO and the GO–AgNP-A nanohybrid are shown in Figure 2a. For both
samples, the peaks observed at 284.4 eV and 531.4 eV are associated with the peaks of C1s and O1s,
respectively. The new peaks at about 368 eV and 374 eV that appear in the spectra of GO–AgNP-A
belong to Ag3d. The high-resolution C1s XPS spectra for GO and GO–AgNP-A are displayed in
Figure 2b,c. By comparing the two spectra, it can be observed that there is a remarkable reduction in
C-O peak intensities, a narrowing of the C-C signal, and the appearance of the shake-up satellite at
about 290.5 eV, characteristics of the aromatic C-C. These results suggest the partial reduction of GO
during the synthesis of the GO–AgNP nanohybrids. The Ag3d spectrum for the GO–AgNP nanohybrid
shows the peaks of Ag3d5/2 and Ag3d3/2 at 368.4 and 374.4 eV, respectively (Figure 2d), indicating
that Ag exists in the metallic form.
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Ag nanoparticles [37].
Table 2. Raman shift positions and intensity ratio (ID/IG) of and – g Ps.
Material D G 2 D+G 2G ID/IG
(cm−1) (cm−1) (cm−1) (cm−1) (cm−1)
GO 1353 1598 2741 2944 3181 0.83±0.02
GO–AgNPs-A 1345 1594 2712 2934 3176 1.03±0.01
XRD Analysis
The crystalline nature of the synthesized GO and GO–AgNP nanohybrid was analyzed by XRD
(Figure 3b). The pattern of GO displays the (001) diffraction peak at 2θ = 11.1◦; according to the Bragg
diffraction formul , the d spacing of GO is .79 nm. Regarding GO–AgNPs, the X-ray diffraction
patterns shows strong Bragg reflecti ns at 38.3◦, 44.2◦, 64.5◦, 77.3◦, and 81.7º of 2θ, which correspond
to th (111), (200), (220), (311), and (222) crystal planes, respectively, of the face-centred cubic crystal
structure of AgNPs. These results corroborate the formation of AgNPs on the GO surface. In addition,
the non-appearance of the GO diffraction pe k aft r the tachment of AgNPs onto its surface suggests
the exfoli tion of GO–AgNP sheets.
TEM
The morphology of the synthesized GO–AgNP nanohybrids was investigated by TEM. Figure 4
shows TEM images, selected area electron diffraction (SAED) patterns of GO–AgNP nanohybrids, and
particle size distributions of AgNPs on GO sheets. The micrographs confirm the decoration of GO with
AgNPs. For all samples, spherical AgNPs well dispersed throughout the GO surface were observed.
For each sample, 1200 nanoparticles in several GO–AgNP micrographs were analyzed to determine
the AgNP sizes.
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It can be seen that the size of the AgNPs is dependent on the AgNO3 concentration and temperature.
The results indicate that the smallest AgNPs are formed at the lowest silver precursor concentration
and temperature. Under these conditions, 1.50 mM AgNO3 and 60 ◦C, the reaction leads to silver
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nanoparticles whose size ranges from 0.9 nm to 5.8 nm, with an average size of 3.1± 0.8 nm (Figure 4a,e),
where about 90% of the AgNPs counted are under 4 nm in diameter. An increase in the silver precursor
concentration results in an increase of the particle size and a broader size distribution when the reaction
temperature is 60 ◦C (Figure 4b,e). Thus, for the GO–AgNP-B nanohybrid, the particle size ranges
from 0.7 nm to 10.8 nm, with an average size of 4.1±1.5 nm, where only 51% of nanoparticles exhibit
diameters less than 4 nm. These findings are in accordance with previous results reported by other
authors [12,22,38–40]. On the other hand, in Figure 4c,d,e, it can be seen that both the size and size
distribution are unaffected by the AgNO3 concentration when the reaction temperature is maintained
at 80 ◦C. Thus, the effect of AgNO3 concentration on AgNP size and size distribution is significant
when the synthesis is performed at lower temperature.
The effect of temperature on silver nanoparticles size can be seen in Figure 4e. It may be noted that
as the temperature increases to 80 ◦C, the nanoparticle size increases and the size distribution becomes
broader. Similar results have been reported in the literature [41,42]. The nucleation of AgNPs on the
graphene oxide surface has been explained through the interaction of silver cations with the oxygen
functional groups. The negatively charged GO sheets allow the attachment of positively charged metal
ions via electrostatic interactions. The addition of L-AA reduces both the Ag+ species to AgNPs and
GO to reduced GO. At higher temperature, the reduction rate of the silver precursor increases, and the
nanoparticle growth reaction rate is faster. From the above results, it can be inferred that both the silver
precursor concentration and temperature are the key parameters for controlling the size of AgNPs.
The sizes of the nanoparticles synthesized in this work are smaller than those reported in the literature
using the solution phase chemical reduction method, either with or without stabilizing agent. In the
present work, only the silver precursor and the reducing agent were used to prepare the nanohybrids,
whereas in most of the reported studies, a stabilizing agent, ultrasonication or a dispersing agent were
also employed.
Several studies have reported the synthesis of AgNPs supported on graphene oxide by using
the solution phase chemical reduction method. Pasricha et al. reported the synthesis of Ag-GO
nanocomposites by chemical reduction of a silver sulfate precursor by GO in the presence of aqueous
KOH at boiling temperature [21]. The results revealed the formation of silver nanoparticles with sizes
in the range of 3−12 nm. Shen et al. synthesized Ag-chemically converted graphene (CCG) by an in
situ solution-based chemical approach with mixed reducing agents at 110 ◦C [14]. The AgNPs on CCG
sheets had a size in the range of 5−10 nm. Das et al. reported the preparation of AgNPs using AgNO3
with sodium borohydride in the presence of GO [12]. The size of the AgNPs obtained by this method
was in the range of 5–25 nm. Tang et al. prepared GO–Ag nanocomposites with different Ag/GO ratios
by chemical reduction of the AgNO3 precursor with sodium citrate at boiling temperature [17]. The
AgNPs that attached onto the GO sheet surface were found to have an average diameter of about 46
nm and 68 nm depending on the Ag/GO ratio. Das et al. reported the synthesis of AgNPs on GO
sheets by chemical reduction of silver metal ions by sodium borohydride in the presence of trisodium
citrate as a stabilizing agent, which showed the formation of silver nanoparticles with a particle size
of 2–25 nm [13]. The results reported by Fonseca de Faria et al. showed GO sheets decorated with
7.5 nm-sized Ag nanoparticles [18]. In their study the GO–Ag nanocomposite was prepared in the
presence of silver nitrate and sodium citrate at 130 ◦C. Hui et al. reported the formation of AgNPs with
an average size ranging from 15 to 55 nm, depending on the ultrasonication time of the mixture of
AgNO3, GO and vitamin C [22].
The insets in Figure 4a–d present the SAED patterns of synthesized AgNPs on GO sheets. They
exhibit diffraction rings and bright spots ascribed to face-centred cubic (fcc) metallic silver. The rings
correspond to the crystallographic planes (111), (200), (220), and (311) of AgNPs. These results are in
agreement with those of XRD and indicate the polycrystalline nature of silver.
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3.1.2. Thermal Stability
The thermal stability of GO and GO–AgNP nanohybrids was measured by TGA under a
nitrogen atmosphere. For GO and all GO–AgNP nanohybrids, the TGA mass loss curves display
two decomposition steps (Figure 5). The first mass loss, attributed to the elimination of interlaminar
water, is found at 50−120 ◦C, and the second, where the decomposition of the oxygen groups occurs, at
140–300 ◦C. During this step, the largest mass loss corresponds to GO (~32%), and decreases as the
concentration of AgNO3 and temperature increase, being 16.1, 7.7, 12.2, and 5.4% for GO–AgNP-A,
GO–AgNP-B, GO–AgNP-C, and GO–AgNP-D, respectively. From these results, it can be concluded
that the most stable hybrid is the one obtained at the highest silver precursor concentration and the
highest temperature. The improvement in the thermal stability is attributed to the deoxygenation and
better graphitization of the hybrids because of the partial reduction of GO.
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coli is a major cause of bloodstream infection, as well as the most common pathogen causing urinary
tract infection and catheter-associated urinary tract infections, and a critical antimicrobial resistance
issue [47]. Multidrug resistance is common in E. coli: Among the most frequent mechanisms are the
production of beta-lactamases and modifications of antibiotic targets. Gram-negative P. aeruginosa is
the main cause of ventilated-associated pneumonia in the intensive care unit and a common cause of
other nosocomial infections exhibiting innate antibiotic multi-drug resistance [48]. We also included C.
albicans because it is the most important cause of healthcare-associated fungal diseases (mycoses). It
is also the most frequent cause of superficial and deep mycoses. In addition, antifungal resistance is
reported in this species although not having the frequency and relevance of resistance in Staphylococcus,
Escherichia or Pseudomonas. C. albicans is the most relevant fungal pathogen since Candida species are
ranked as the fourth or fifth most common nosocomial bloodstream pathogen in the USA and some
European countries, with mortality rates as high as 45% [44,49].
The antimicrobial activity of GO and GO–AgNP nanohybrids was analyzed by means of the
MIC determination and the microbial growth kinetics assay of E. coli ATCC 25922, P. aeruginosa ATCC
27853, S. aureus ATCC 25923, and C. albicans SC5314. The strains selected in the current study are
recommended for in vitro susceptibility testing. The GO–AgNP-A sample was selected for the study
of antimicrobial properties. MIC values are shown in Table 3.
Table 3. Minimum inhibition concentrations of GO and GO–AgNP-A.
MIC (µg/mL)
Microorganism GO GO–AgNP-A
Escherichia coli >128 64
Pseudomonas aeruginosa >128 64
Staphylococcus aureus >128 32
Candida albicans >128 32
For the GO sample with concentrations within the range of 0.25 µg/mL to 128 µg/mL, a 50%
reduction in absorbance with respect to the absorbance of the growth control of any of the four
microorganisms studied was not observed. Therefore, the GO used in the present study did not
exhibit antimicrobial activity at the concentrations up to maximum tested 128 µg/mL. In the case
of GO–AgNP-A, the growth of the microorganisms was inhibited by at least 50% above a certain
concentration, which depends on the microorganism. The MIC value for Gram-negative bacteria was
64 µg/mL, while for S. aureus and C. albicans, 32 µg/mL, after 24 h exposure.
The microbial growth kinetics test offers an interesting approach to study the antimicrobial activity
since it takes into consideration the influence of two important variables: the amount of nanomaterial
and the exposure time (longer than in the MIC test) of microbial cells to the nanomaterial. The
absorbance of the microplate wells was monitored every hour, which allowed us to establish the growth
curves (Figure 6). Owing to the lack of antimicrobial activity found for GO in the previous assay, it
was used as a negative inhibition control in this test, and the growth kinetics of the microorganisms
were observed in the presence of the highest GO concentration previously tested (128 µg/mL) for 72 h.
It can be noted that GO did not prevent the growth of any of the microorganisms used in the present
study, confirming once again the lack of antimicrobial activity in the concentration range studied. In
addition, GO acts as a growth stimulator, as the growth curve of microorganisms in contact with the
nanomaterial exceeded the absorbance of those that had not been in contact, which is in accordance
with the results reported in the literature [50,51].
Nanomaterials 2020, 10, 376 13 of 22
Nanomaterials 2020, 10, x FOR PEER REVIEW 13 of 22 
 
 
Figure 6. Microbial growth kinetics in contact with GO. (a) C. albicans, (b) S. aureus, (c) P. aeruginosa, 
and (d) E. coli. 
Several studies have investigated the antimicrobial properties of GO, and the reported results 
have been controversial [50–53]. The discrepancies in the published data have been attributed to 
differences in the physical-chemical characteristics of the GO used. The size, surface area, functional 
groups, oxygen content, surface roughness, layer number, purity, and arrangement mode 
of GO sheets affect their antimicrobial properties. Both the graphite source and the level of 
oxidation/exfoliation, governed by the preparation method, determine most of these features. The 
lateral size of GO sheets has been shown to affect their antimicrobial activity. Higher antibacterial 
activity is displayed by small lateral-sized GO when in the form of surface coating [54], whereas large 
sheets are more toxic to bacteria for dispersed GO [55]. In addition to the above-mentioned factors, 
which depend to a very high extent on the type of graphite, the antimicrobial effects of GO are 
influenced by its concentration, the incubation conditions, exposure time, and the characteristics of 
microorganisms used. Liu et al. [52] demonstrated that several graphene material dispersions had 
concentration- and time-dependent antibacterial activity. In their study, the incubation of GO 
dispersions (at concentrations from 10 to 80 μg/mL) with E. coli cells showed the highest antibacterial 
activity among the different graphene-base materials studied and an almost complete loss of cell 
viability at a concentration of 80 μg/mL. Moreover, most of the bacterial inactivation was observed 
in the first hour of incubation. Hu et al. reported the growth inhibition of E. coli bacteria by GO, being 
almost completely suppressed when treated with 85 μg/mL GO for 2 h [53]. Other studies, however, 
have shown the contrary. In the study by Nguyen et al., the ineffectiveness of GO (up to 400 μg/mL) 
against E. coli was demonstrated [56]. The lack of antifungal activity against C. albicans by GO was 
demonstrated in the studies carried out by Li et al. [57] and Al-Thani et al. [58]. Ruiz et al. reported a 
rapid and irreversible attachment of bacterial cells to GO [50]. 
Physical and chemical interactions between GO and bacterial cells are responsible for the 
antibacterial properties of the GO. When bacterial cells come into direct contact with the sharp edges 
or basal planes of GO, membrane stress of bacteria can be induced, resulting in disruption and 
physical damage to cell membranes. The sharp edges of graphene sheets act as nanoknives, cutting 
i r . i r i l r t i ti s i t t it . ( ) . l ic s, ( ) . re s, ( ) . er i s ,
( ) . li.
[ ]. The iscre ancies i
ff i t i l- i l t i ti t .
, oxygen conte t, surface roughness, layer number, purity, and arrangement mode of GO sheets
affect their antimi robial propert es. Both the graphite source and the level of oxidation/exfoliation,
governed by the preparation method, determine most of these f atures. The lateral size of GO heets
has been sh wn to affect their antimicrobial activity. Higher anti acterial activity is displayed by
small lateral-sized GO when in he form of surface coating [54], whereas large sheets are mo toxic to
bacteri for dispersed GO [55]. In ad ition to the above-mentioned factors, which depe d to ve y
high extent on the typ of graphite, the a timicrobial effects of GO are influenced by its oncentration,
the incubation conditions, exposure time, and the characteristics f microorganisms used. Liu et al. [52]
dem nstrated that several gr phene material dispersions had concentration- and time-dependent
antibac erial activity. In their stu y, the incubation of GO dispersions (a concentrations from 10 to 80
µg/mL) with E. coli cells sh wed the highest antibacterial activ ty among the different gr phene-base
materials studied an an almost complete loss of cell viability at a conce tration of 80 µg/mL. Moreov r,
most of the bacterial inactivation was observed in the first hour of incubat on. Hu et al. rep rted the
growth inhibition of E. coli bacteria by GO, being almost completely suppressed when treated with 85
µg/mL GO for 2 h [53]. Oth r studies, however, have shown the contrary. In the st y by Nguy n
et al., the i eff ctiveness of GO (up to 400 µg/mL) against E. coli was dem nstrated [56]. The lack
of ntifunga activity against C. albicans by GO was demonstr ted n the studies carried out by Li et
al. [57] and Al-Thani et al. [58]. Ruiz e al. reported a r pid and irreversible attachment of bacterial
cells to GO [50].
t rial roperties of the GO. When bacterial cells come into direct ontact with t e sharp edges or
Nanomaterials 2020, 10, 376 14 of 22
basal planes of GO, membrane stress of bacteria can be induced, resulting in disruption and physical
damage to cell membranes. The sharp edges of graphene sheets act as nanoknives, cutting the bacterial
cell membrane, which leads to the leakage of intracellular components followed by cell death [59].
Wrapping and trapping of bacterial membranes by the flexible thin sheets of GO after their direct contact
has also been proposed as another antimicrobial mechanism of the graphene materials [54,55,60]. In this
scenario, bacterial cells die by being isolated from the growth medium. Oxidative stress is considered
a predominant mechanism of bacterial inactivation of GO [59,61]. In bacterial cells exposed to GO,
oxidative interactions play a key role due to the oxidation capacity of graphene material. Oxidative
stress can occur through either a reactive oxygen species (ROS)-dependent or a ROS-independent
pathway. In the first case, oxidative stress is mediated by the production of ROS, which can damage
cellular components. In the second one, however, the production of ROS is not involved, being the
charge transfer from the cellular membrane to graphene surface that induces cell death. Ruiz et al. [50]
investigated the effect of colloidal GO on bacterial (E. coli) growth in Luria–Bertani (LB) nutrient
broth, observing a dramatic increase in microbial cell proliferation. The microbial assays showed the
precipitation of GO in the culture media when bacteria were present. The scanning electron microscopy
(SEM) analysis of this precipitate revealed that it was formed by a thick bacterial biofilm containing a
large mass of aggregated cells and extracellular polymeric material. The authors suggested that the
GO precipitates acted as scaffolds for cell surface attachment, proliferation, and biofilm formation.
Chen et al. [51] also found the formation of anaerobic membrane scaffolds by GO suspensions in
bacterial growth medium, which facilitated proliferation of gut microbiota. Hui et al. [62] studied the
antimicrobial properties of GO in saline and LB broth. The results showed that LB broth made GO
inactive, observing an increase in bacterial growth. The loss of antibacterial activity was attributed to
the noncovalent adsorption of LB components on GO basal planes. From the above-mentioned studies,
it has been inferred that the culture medium plays a key role in the toxicity of GO against bacteria.
More recently, Gusev et al. [63], in their study of the interaction of E. coli with reduced graphene oxide
(rGO), also demonstrated the important role of the culture medium in the antimicrobial properties
of rGO.
Regarding the GO–AgNP-A sample, MIC/2, MIC, and MICx2 were the nanomaterial concentrations
analyzed for each microorganism. The results obtained are presented in Figure 7, where it can be
observed that microbial growth was completely prevented at one of the concentrations for all the
microorganisms. The curves show four distinct growth phases, lag, log, stationary, and death phases.
The lag phase corresponds to the delay before exponential growth begins. In the log or exponential
phase, cell division proceeds at a constant rate, whereas in the stationary phase, the conditions become
unfavorable for growth and microbes stop replicating and reach an equilibrium level. Finally, in
the death phase, cells lose viability. The length of the lag phase is the time that it takes for the
different inoculums before an increase in cell number is observed. When microorganisms are cultivated
in fresh medium and have to face environmental changes, they enter the lag phase, during which
cell growth stops. This allows the cells to adapt to the new situation and to synthesize the cellular
components necessary for growth. Depending on the cell structure, the type of antimicrobial agent
and its concentration, the growth profile differs [64].
According to Table 3, the MIC value for C. albicans was 32 µg/mL, and this can also be confirmed
in the growth curves (Figure 7a) where the yeast growth was inhibited for 24 h at this concentration.
However, 64 µg/mL of GO–AgNP-A was required to fully inhibit the growth of C. albicans after 50 h of
incubation with the nanomaterial. For S. aureus, the concentration causing at least 50% growth inhibition
was also 32 µg/mL, although after 35 h, the inhibitory effect disappeared (Figure 7b), and 64 µg/mL of
GO–AgNP-A inhibited the growth of S. aureus until 60 h. On the other hand, the two Gram-negative
bacteria had an MIC value of 64 µg/mL. However, the antibacterial effect of this concentration on
P. aeruginosa ceased after 32 h, while with respect to E. coli, the antibacterial effect was stable over
time (Figure 7c,d). In view of all the results, it could be concluded that the GO–AgNP-A nanohybrid
exhibited dose- and time-dependent antimicrobial activity. The concentration of GO–AgNP-A that
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would hinder the growth of any of these microorganisms, at least for 72 hours, would be higher than
64 µg/mL. These results indicate that the highest susceptibility to the GO–AgNP-A nanohybrid was
shown by C. albicans and S. aureus. The differences found in the antimicrobial effect of the nanomaterial
could be due to the different cell wall structures of the four microorganisms, involving a species-specific
mechanism as indicated by Tang et al. [17].
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al. reported that graphene oxi e dispersion lacked antibacteri l activity against P. aeruginosa at t e
eval ate conce trati s i the study (0.1 to 5.0 µg/mL) after different exposure times, whereas 100%
of . aeruginosa cells were fully inhibited after contact with GO/Ag concentrations of 2.5 and .0 µg/mL
for 30–60 min [18]. Cui et al. investigat d the inhibitory effect against C. albicans of both GO and the
GO–Ag composite [65]. They found that GO did not exhibit growth inhibition of fungal cells, while
the study confirmed that GO–Ag had antifu gal properties. Moreover, the antifungal property was
enhanced when compared with that of bare AgNPs. Jaworski et al. studied the antimicrobial activity
of GO-, AgNP-, and GO–AgNP-coated polyurethane foils against E. coli, S. aureus, S. epidermidis, and C.
albicans at 37 ◦C for 24 h [66]. The foil coated with GO–Ag showed the strongest antibacterial effect
against all tested microorganisms; the growth of bacterial cells as greatly inhibited, while th GO-
and AgNP-coated films o ly slightly reduced it. The yeast C. albicans was the most resistant to the
d leterious effect of GO–Ag, foll wed by Gram-positive and Gram-negative bacteria. The study carried
out by Tang et al. reveal that oth pur GO and AgNPs and t e simple mixture of both had no effect
on E. coli and S. aureus at the c centratio s studied, whereas the nanoc mposite GO–Ag showed
dose- and Ag:GO ratio-dependent antib cterial activity [17]. In a dition, the results showed that the
antibacterial eff ct of GO–AgNPs was species-specific dependent. The enhanced antimicrobial activity
of GO–AgNPs compared to GO and AgNPs is attributed to a synergistic effect of GO an AgNPs and not
to an ad itive effect of both components. Shao et al. investigated the antibact rial activity of a GO–Ag
Nanomaterials 2020, 10, 376 16 of 22
nanocomposite against E. coli and S. aureus [67]. The synthesized GO–Ag showed a dose-dependent
antimicrobial effect and was stronger towards E. coli than towards S. aureus. Das et al. investigated the
antibacterial activity of Ag-GO against E. coli and P. aeruginosa [12]. They found that P. aeruginosa was
more sensitive than E. coli to Ag-GO. The investigation of the antibacterial activity of a GO–Ag hybrid
by Mohammadnejad et al. showed a higher toxicity against E. coli than against S. aureus [68].
The results of the present work suggest that AgNPs play a pivotal role in the antimicrobial
activity of GO/AgNP hybrids. The activity of AgNPs is dependent on several parameters, including
those inherent to them such as size and shape. The size dependency has been examined in various
studies [7,9,10,69–72]. The smaller the size, the higher the toxicity. Small-sized AgNPs have a larger
surface area, resulting in more efficient cell–particle contact. Bare-silver nanoparticles are not stable in
aqueous suspensions and have a tendency to aggregate, which limits their applications. GO plays
an active role in the enhancement of the stability of the AgNPs, acting as a platform to prevent their
agglomeration. The formation mechanism of the GO–AgNP hybrids seems to be through electrostatic
interactions between the negatively charged oxygen-containing functional groups on the GO surface
and the free silver ions, which are then reduced by the reducing agent, leading to the formation of
AgNPs attached to the GO surface [11,18,21,22,67,73,74].
AgNPs have been widely investigated by numerous researchers [10,71,75–83], and most of the
studies reported have been focused on their antimicrobial properties. Their mechanism of antimicrobial
action, however, remains unclear and is still under debate. The possible mechanism includes the
attachment of AgNPs to the microbial surface, which is thought to be mediated by electrostatic
interaction between the negatively charged cell membrane of many microbes and positive surface
charged nanoparticles. Once the nanoparticles have adhered to the microbial cells, they are able to
penetrate into them, resulting in damage of their internal components. The cellular internalisation
of AgNPs can also generate ROS and induce oxidative stress in bacterial cells due to released Ag+
ions. In the presence of dissolved oxygen (in aqueous solutions), the surface of silver nanoparticles is
oxidized, and the AgNP oxidative dissolution leads to Ag+ ions. Both AgNPs and Ag+ ions damage
microbial cells by interacting with sulfur-containing proteins (the thiol group of proteins, which
are responsible for enzymatic activity) present in microbial membranes or inside these cells, and
with phosphorus-containing compounds such as DNA. This chemical interaction can result in the
inactivation of such proteins in the microbial cell wall. All these processes will finally lead to the death
of microorganisms. The antimicrobial effect of GO–AgNP nanohybrids could be explained by the
combined action of direct contact between the AgNPs and the microbial cells and the dissolution of
Ag+ ions from the silver nanoparticles.
There is an increasing number of patients carrying biomedical devices. Severe infectious diseases
associated with their use cause great morbidity and mortality, especially in critically ill people [84].
These types of GO–AgNP nanohybrids have found applications in different areas, as was previously
mentioned. Their antimicrobial properties make them appropriate for being used in the field of
biomedicine, as well as in the preparation of polymer nanocomposites with antimicrobial properties.
In previous work, we incorporated this new class of antimicrobial materials into poly(vinyl alcohol), a
biocompatible and biodegradable polymer, to fabricate an antimicrobial polymer nanocomposite [85]
that could be a potential wound-dressing material.
The matter of cytotoxicity of nanomaterials is a particularly important aspect to consider in the
applications of these materials in the biomedical field. The cytotoxicity of nanomaterials is governed by
their physicochemical properties such as size, shape, surface charge, coating, and concentration [34,86].
AgNPs have been found to be toxic to several human cell lines, and their cytotoxicity occurs in a
dose-, size-, and time-responsive manner (especially for those with sizes ≤10 nm) by creating ROS,
oxidative stress, and DNA damage [87–89]. The smaller silver nanoparticles showed higher biological
activity in comparison with the larger ones. However, the toxicity threshold for the same cell line was
higher for small particles than for large ones. [90]. No cytotoxicity has been observed when AgNPs
are coated with appropriate polymers at certain concentrations [91]. From the reported studies, it is
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inferred that AgNPs have many beneficial effects and applications when the doses are reasonable
without adverse effects on human cells [92,93]. Concerning GO–AgNP cytotoxicity, it has been reported
that this also occurs in a dose-dependent manner and is affected by the mass ratio of GO:Ag. It has
been found that GO–AgNPs are more toxic than their pristine counterparts. The reported studies
revealed that the cytotoxicity of GO–AgNPs towards human cell is related to the synergistic effect
between GO and AgNPs [87]. As with any other compound, the dose of GO–AgNP nanohybrids
to be used in their applications will have to be considered to avoid adverse effects. On the other
hand, the anticancer activity of GO, AgNPs, and GO–AgNP nanohybrids against different cancer cells
has been reported [94,95]. Silver nanoparticle-decorated graphene oxide shows enhanced anticancer
activity compared to GO [96]. Therefore, GO–AgNP nanohybrids could have potential applications in
theranostics for cancer [97,98].
4. Conclusions
GO–AgNP nanohybrids were successfully synthesized by an environmentally friendly one-step
approach in the absence of any stabilizer. The simultaneous reduction of AgNO3 and GO in the
presence of ascorbic acid resulted in the decoration of partially reduced graphene oxide with uniformly
distributed AgNPs of an average size less than 4 nm. The size of the silver nanoparticles was
determined by the concentration of the silver precursor and temperature. The effect of the former
was more significant at lower temperature. The lower the concentration of silver precursor and the
lower the temperature, the smaller the size of the silver nanoparticles anchored on the GO surface.
GO dispersion lacked antimicrobial activity against four common pathogens, E. coli, P. aeruginosa, S.
aureus, and C. albicans over the concentration range investigated, while the nanohybrids exhibited
species-specific antimicrobial activity. GO–AgNPs displayed the highest activity against C. albicans
and S. aureus. GO–AgNP nanohybrids induced a dose- and time-dependent toxicity against the four
microorganisms. This class of nanohybrids can be used as antimicrobial fillers for the preparation of
polymer nanocomposites with antimicrobial properties, which can find applications in different fields,
and they could also be considered non-toxic agents for application in cancer therapy.
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